Virtu Financial’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-312
| Closed | -$36K | – | 2356 |
|
|
2022
Q3 | $36K | Buy |
312
+280
| +875% | +$32.3K | ﹤0.01% | 1277 |
|
|
2022
Q2 | $6K | Buy |
+32
| New | +$6K | ﹤0.01% | 1456 |
|
|
2021
Q1 | – | Sell |
-160
| Closed | -$167K | – | 2183 |
|
|
2020
Q4 | $167K | Buy |
+160
| New | +$167K | 0.02% | 918 |
|
|
2019
Q3 | – | Sell |
-49
| Closed | -$54K | – | 1934 |
|
|
2019
Q2 | $54K | Buy |
49
+41
| +513% | +$45.2K | ﹤0.01% | 1205 |
|
|
2019
Q1 | $21K | Buy |
8
+6
| +300% | +$15.8K | ﹤0.01% | 1271 |
|
|
2018
Q4 | $8K | Sell |
2
-12
| -86% | -$48K | ﹤0.01% | 1452 |
|
|
2018
Q3 | $40K | Buy |
+14
| New | +$40K | ﹤0.01% | 1322 |
|
|
2018
Q2 | – | Sell |
-3
| Closed | -$35K | – | 2625 |
|
|
2018
Q1 | $35K | Hold |
3
| – | – | ﹤0.01% | 1763 |
|
|
2017
Q4 | $129K | Buy |
+3
| New | +$129K | 0.01% | 1834 |
|